Adaptive Biotechnologies Corp.

Adaptive Biotechnologies is a leading innovator in the field of immune medicine. Focused on unlocking the power of the adaptive immune system, the company has developed a platform that can read and translate the immune system at scale and with precision. Adaptive's technology allows them to develop a range of products, including diagnostic tests like clonoSEQ for minimal residual disease (MRD) detection in blood cancers, as well as therapeutic modalities like TCR therapies for cancer and antibody therapeutics for infectious diseases.

Adaptive Biotechnologies is committed to advancing science and enabling a new dimension of healthcare, opening up new possibilities for patients. The company emphasizes a people-centric culture and actively pursues corporate social responsibility initiatives, supporting STEM education for girls of color and fostering an inclusive workplace. Adaptive's mission is to translate the genetic language of the adaptive immune system into clinical products to diagnose and treat disease, ultimately aiming to transform how we detect and treat illness.

Adaptive Biotechnologies offers a variety of benefits that support employee flexibility, including comprehensive healthcare plans, commuter support, and a 401(k) with company match. For employees in Seattle, Adaptive provides a company-paid ORCA card for public transit. The company also offers generous time off plans for full-time employees and six weeks of Adaptive paid parental leave for new parents in addition to short term disability.

Adaptive Biotechnologies offers a comprehensive benefits package that includes healthcare coverage with employer contributions, commuter benefits, a 401(k) plan with a match, short and long-term disability, life and AD&D insurance, mental wellness support, paid holidays, sick and safe leave, generous time off, and 6 weeks of paid parental leave.

Adaptive Biotechnologies is dedicated to revolutionizing healthcare by unlocking the power of the adaptive immune system. They believe that by decoding the unique stories told by each individual's immune system, they can develop innovative clinical diagnostics and therapeutics to diagnose and treat a wide range of diseases, including cancer, autoimmune disorders, infectious diseases, and neurodegenerative disorders. Adaptive's mission is to translate the genetic language of the immune system into clinical products that can improve the lives of patients around the world.

Adaptive Biotechnologies fosters a culture that values innovation, integrity, collaboration, and open dialogue. They encourage employees to push boundaries and think boldly, while emphasizing the importance of working together and valuing different perspectives. The company prioritizes a people-centric culture, believing that this enables all Adapters to succeed and thrive, ultimately helping them achieve their mission of advancing immune-driven medicine.

Adaptive Biotechnologies is committed to fostering a diverse, equitable, and inclusive workplace. The company actively supports organizations promoting STEM careers for women of color, provides employee resource groups for various identities and backgrounds, and achieved a 95 out of 100 score on the Human Rights Campaign Foundation's Corporate Equality Index, a measure of LGBTQ+ workplace equality. They believe that a people-centric culture enables all employees to thrive and contribute to their shared mission of advancing immune-driven medicine and improving patient outcomes.